Agent Capital

Venture firm

Agent Capital investment thesis

About Portfolio Strategy News Contact About Portfolio Strategy News Contact TODAY'S INVESTMENT. TOMORROW'S BREAKTHROUGH. Addressing unmet patient needs through groundbreaking innovations INVESTMENTS THAT MATTER Agent Capital is a healthcare venture capital firm focused on investing in novel, differentiated therapeutics and treatments that address unmet patient needs. Across all stages of development, we align ourselves with scientists, entrepreneurs and other investors to develop the next generation of healthcare innovations that will have a positive impact on patients’ lives. Learn More OUR PROVEN STRATEGY At Agent Capital, we proactively guide biotech companies to milestones and exits. With a balanced investment approach and a deep understanding of biopharma’s pipeline pressures, we are

Agent Capital team (4)

Partners and principals at Agent Capital:

Agent Capital portfolio companies

Companies listed on Agent Capital's public materials include: About, Portfolio, Strategy, News, Stage Stage Preclinical Clinical Commercial, Status Status Active Public M&A, Clear, Affini-T, Visit Site, Alveus Therapeutics, AshiBio, Carbon Biosciences, Carisma Therapeutics, Cerevance, Cyrus Biotechnology, Dice Therapeutics, Dragonfly Therapeutics, Entrada Therapeutics, Flare Therapeutics, Foresight Diagnostics, Freenome, GlycoEra, Hinge Bio, ImCheck Therapeutics, Immunitas Therapeutics, Interius BioTherapeutics, Mediar Therapeutics, Metagenomi, Nu-Tek Biosciences, Orbital Therapeutics, Orbus Therapeutics, Orchard Therapeutics, Palvella Therapeutics, Pliant Therapeutics, Precision Biosciences, Primrose Bio, Pyxis Oncology, Q32 Bio, Skyhawk Therapeutics, Star Therapeutics, TRex Bio, Verge Genomics, ViTToria Biotherapeutics, Zenas Biopharma.

Is Agent Capital a fit for your round?

Upload your pitch deck and see whether anyone at Agent Capital appears in your top matches.

Find investors for your deck